CTRI/2020/08/027044尚未招募2 期
Proposal for Ayurvedic Management Protocol and Add-on to the Standard care for Covid-19
Shri Krishna Ayush University0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. RT_PCR based laboratory confirmation test for COVID-19
- •2.Typical clinical presentation of acute onset febrile illness with sore throat and dry cough with or without shortness of breath in a patient from a known â??hot spotâ?? area or in close contact with a confirmed COVID-19 case with a negative laboratory test for COVID 19 and H1N1 influenza.
- •3. Patients with either sex, 18 to 60 years age.
- •4. Patients who can take oral medicine.
- •5. Uncomplicated illness and Mild Pneumonia Cases
- •6. Patients with mild-moderately severe disease
- •7. All patients must agree not to share medication
- •8. Patients willing to participate and sign an informed consent Understands and agrees to comply with planned study procedures.
- •9.Agrees to the give OP swabs and venous blood for testing as per Protocol.
排除标准
- •1. Patients suffering from severe COVID-19 Disease as judged by a physician and fulfilling at least two of the following three criteria
- •(i) Respiratory distress at room ambience (equal or more than 30 breaths per min)
- •(ii) Oxygen saturation at rest equal or less than 93% (peripheral digital arterial oxymetry) and requiring oxygen support for over one hour to normalize
- •(iii) Any of the known COVID-19 complications and emergency procedures which may require shift/admission in intensive care unit such as respiratory failure, adult respiratory distress syndrome, requirement of oxygen support for over 1 hour, requirement of mechanical ventilation, septic shock, or severe non-respiratory organ dysfunction or failure.
- •2. Chronic, Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study
- •3. History of immunosuppression: solid organ or bone marrow transplant, use of immunosuppressive antimetabolic and biologic agents, intrinsic immunodeficiencies, HIV infection.
- •4. Active cancer diagnosis, on palliative treatment or requiring current therapy with antimetabolic agents, immunotherapy or radiotherapy.
- •5. Patients on parenteral nutrition
- •6. Patients with known sensitivity or contraindication to any of the ingredients of study medication
- •7. History of bleeding haemorrhoids, haemoptysis, acid peptic diseases, ulcers and pulmonary diseases (tuberculosis, asthma, etc.)
- •8. Patients who are likely to worsen or planed ICU admission or ventilator support due to any reason.
- •9. Pregnancy and lactation
- •10. Participation in a drug interventional clinical drug trial of any nature in the three month period preceding onset of COVID-19
- •11. Participation in any other clinical trial of an experimental agent treatment for COVID-19
- •12. Patients on any kind of Ayurveda treatment or any other alternative and complementary medicinal systems such as Homeopathy, Unani, Siddha and in particular requiring oral therapy of any kind.
- •13. Physician decision that involvement in the study is not in the patient´s best interest.
研究者
相似试验
尚未招募
3 期
Ayurveda Treatment Protocol in Management of Female Infertility due to Tubal BlockageCTRI/2022/01/039751Institute of teaching and research in Ayurveda Jamnagar
尚未招募
Unknown
Management of osteoarthritis of knee joint with ayurvedic treatmentCTRI/2023/03/051147J S Ayurveda Mahavidyalaya
已完成
不适用
AYURVEDIC MANAGEMENT IN HYPOTHYROIDISMCTRI/2021/12/038495Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP38
招募中
3 期
Ayurvedic intervention for prevention of acute pain crises in Sickle Cell AnaemiaCTRI/2023/04/052141Central Council for Research in Ayurvedic Sciences
招募中
3 期
Ayurvedic treatment for Metabolic Syndrome a disease which includes obesity, elevated blood pressure, abnormal lipids with early diabetes at one placeCTRI/2015/06/005899Adesh University1,000